Stocks›Healthcare›CAI

CAI

CARIS LIFE SCIENCES, INC.

NasdaqResearch view

Healthcare · Services-Medical Laboratories · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$8.5B

Enterprise Value$8.1B

Income$-68.1M

Sales$812.0M

Book/sh$2.04

Cash/sh$2.83

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio—

Current Ratio7.85

Debt/Eq0.66

EPS (ttm)$-3.22

EPS this Y69.8%

EPS past 3/5Y—

Sales past 3/5Y—

EPS Y/Y TTM69.8%

Sales Y/Y TTM97.0%

Shs Outstand282.60M

ROA-6.0%

ROE-11.8%

ROIC28.9%

Gross Margin—

Oper. Margin5.6%

Profit Margin-8.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$306.1M

2023

$412.3M

2024

$812.0M

2025

Financials — annual

SEC EDGAR · last 3 FY · tap a row to explain it

USD	FY2023	FY2024	FY2025
Revenue	$306.1M	$412.3M	$812.0M
Gross Profit	—	—	—
Operating Income	$-319.6M	$-257.1M	$45.1M
Net Income	$-341.4M	$-281.9M	$-68.1M
Diluted EPS	$-13.24	$-10.66	$-3.22
Operating Cash Flow	$-276.1M	$-245.2M	$83.2M
Free Cash Flow	$-298.4M	$-253.6M	$66.9M